Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,330 shares at $21.38 ($28K) on 2023-05-17, disclosed to the SEC on 2023-05-19.
Open-market sale of $28k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |